Rossari Biotech enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


2,257	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
114	110	102	62.8	95.8
408	408	188	106	73.9
2,551	—	—	—	—
294	298	86.5	43.1	−21.9
₹460.60	—	—	—	—

1,816	1,741	1,373	1,154	989
22.5%	23.4%	13.7%	9.2%	7.5%
0.16×	—	—	—	—

0.96×	—	—	—	—
8.13×	—	—	—	—
11.87×	—	—	—	—
2,661	2,396	2,080	1,831	1,656
314	286	265	250	223
215	207	198	189	160
—	65.1	137	43.3	152
−200	−200	−21.1	−88.0	120
—	−206	−25.4	−92.3	118
—	265	159	131	32.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ROSSARI₹407.60

Rossari Biotech Limited

· Chemicals

₹ CrorePeersNOCIL HSCL NAVINFLUOR DDEVPLSTIK CHEMPLASTS TATACHEM AARTIIND JGCHEMMcap ₹2,257 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	2,257.5
- Cash, Equiv & ST Investments	95.8	62.8	101.5	110.4	114.5
+ Total Debt	73.9	105.8	188.0	408.0	408.0
Enterprise Value	—	—	—	—	2,551.0
Net Debt (memo)	-21.9	43.1	86.5	297.6	293.5
EV per Share	—	—	—	—	460.60

Total Capital	989.1	1,153.6	1,373.4	1,741.3	1,815.6
Total Debt/Total Capital	7.47	9.17	13.69	23.43	22.47
Total Debt/EV	—	—	—	—	0.16

EV/Sales	—	—	—	—	0.96
EV/EBITDA	—	—	—	—	8.13
EV/EBIT	—	—	—	—	11.87
Reference Items — Trailing FY Values
Sales	1,655.9	1,830.6	2,080.3	2,396.4	2,661.3
EBITDA	223.0	249.8	265.1	285.9	313.7
EBIT	160.1	189.4	198.0	206.8	214.9
Operating Cash Flow	152.4	43.3	137.4	65.1	—
Free Cash Flow	119.5	-88.0	-21.1	-199.6	-199.6
FCFF (free cash flow to the firm)	117.9	-92.3	-25.4	-206.3	—
Capital Expenditure	32.9	131.3	158.5	264.7	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.